Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Kivu Bioscience Inc.
ViroMissile, Inc.
Arcus Biosciences, Inc.
Tizona Therapeutics, Inc
Eli Lilly and Company
MacroGenics
SystImmune Inc.
Pheon Therapeutics
Eli Lilly and Company
Orano Med LLC
Eli Lilly and Company
Innate Pharma
Radiopharm Theranostics, Ltd
HiFiBiO Therapeutics
Rondo Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Chongqing Precision Biotech Co., Ltd
Nurix Therapeutics, Inc.
Pfizer
Arcus Biosciences, Inc.
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Sichuan Enray Pharmaceutical Sciences Company
University of Virginia
Incyte Corporation
Anhui Provincial Hospital
NextPoint Therapeutics, Inc.
HC Biopharma Inc.
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Exelixis
Rutgers, The State University of New Jersey
Seagen Inc.
Seagen Inc.
Seagen Inc.
Sotio Biotech Inc.
Anhui Provincial Hospital
Symphogen A/S
Vincerx Pharma, Inc.
AstraZeneca
Molecular Templates, Inc.
NGM Biopharmaceuticals, Inc
Xencor, Inc.
Adlai Nortye Biopharma Co., Ltd.
Advaxis, Inc.
NGM Biopharmaceuticals, Inc
Myeloid Therapeutics